Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Int J Gynecol Cancer. 2022 Aug 1;32(8):1017–1024. doi: 10.1136/ijgc-2022-003430

Table 2:

Patient demographic variables by individual patient

Patient Age at Diagnosis Germline Mutation Stage Neoadjuvant Chemotherapy Surgery Outcome Concurrent Endometriosis
1 69 negative IVB No OD No
2 58 negative IIA No CGR No
3 34 negative IIIC Yes SD Yes
4 67 - IC No OD No
5 63 PMS2 IIIA1 No CGR Yes
6 53 negative IVB No OD Yes
7 50 negative IIIC No OD Yes
8 38 negative IVB Yes CGR Yes
9 49 SDHA IIIA2 No CGR Yes
10 47 negative IIIB No OD Yes
11 54 BRCA1 IVB No SD No
12 62 negative IIIC Yes OD No
13 48 - IC No - No
14 58 - IIIB No - Yes
15 42 - IV Yes - No
16 47 - IIIA No CGR Yes

OD: optimal debulking; CGR: complete gross resection; SD: suboptimal debulking